Tecnimede Group, a 100% Portuguese pharmaceutical entity founded in 1980, has established itself with a global presence rooted in quality and innovation. Upholding their slogan, "Elevating lives worth living," Tecnimede has cultivated a portfolio of over 100 products, making their medicines accessible in more than 100 countries. Their direct presence spans Portugal, Spain, Italy, Morocco, Colombia, and Brazil.
Guided by values of integrity, loyalty, courage, and perseverance, Tecnimede emphasizes responsible and transparent practices. With a mission to leverage medical science and technology, the company aims to enhance global quality of life sustainably. The firm champions innovation, collaboration, and respect, translating science into tangible health solutions.
Currently, there is no reported recent investment activity, suggesting an opportunity for investors interested in established entities striving for impactful global health outcomes. With headquarters in Portugal, Tecnimede Group presents a compelling opportunity for ethical and mission-driven investment in the pharmaceutical sector.